Atención farmacéutica en obesidad. Utilidad de las plantas medicinales en su tratamiento

  1. METODIEVA, Mihaela
  2. FUENTES, José Enrique 1
  1. 1 Farmacia J. E. Fuentes
Aldizkaria:
Farmajournal

ISSN: 2445-1355

Argitalpen urtea: 2016

Alea: 1

Zenbakia: 2

Orrialdeak: 143-149

Mota: Artikulua

Beste argitalpen batzuk: Farmajournal

Laburpena

Obesity is defined as a multifactorial chronic disease, characterised for the increase of fat mass and corporal weight, as consequence of a positive energetic balance. It is related to hypercaloric diets, with high content in saturated fats and simple carbon hydrates, innadecuated life-styles like sedentarism. It is a cardiovascular risk factor and it has a high prevalence. The goals of this study are: analyse the derivated risk factors from obesity, a review of the physiotherapeutic possibilities for obesity and analyse the results from the intervention made in a community pharmacy. From this study we concluded that women are more interested in loose weight than men. By the intervention made in the community pharmacy, more than 63% of the cases lost weight in a moderated way, and between 5 and 10% in a sustained way.By changing diets, doing moderate exercise, and with medicinal plants the weight loss can be 800-900g and even 1 kg per week

Erreferentzia bibliografikoak

  • Agencia Europea del Medicamento (EMA) [página Web]; [acceso 5-10 de mayo de 2014]. Disponible en: http://www.ema.europa.eu/ema/
  • Angulo E, Jiménez A, Álamo J, Garmendia C. Experiencia de educación nutricional en la oficina de farmacia. Rev Esp Nutr Comunitaria. 2002; 8 (1-2): 42-45.
  • Navarro C, Ortega T, Rubio MA, Román J. Plantas medicinales para el sobrepeso. Editorial Complutense; Madrid 2009.
  • García JA, Marta Álvarez O. Plantas medicinales en el tratamiento de la obesidad. Offarm. 2002; 21 (9): 132-144.
  • Rodríguez-Artelejo F, Graciani A, Guallar-Castillón P, León-Muñóz LM, Zuluaga MC, López-García E, et al. Justificación y métodos del estudio sobre nutrición y riesgo cardiovascular en España (ENRICA). Rev Esp Cardiol. 2011; 64 (10): 876-882.
  • Zugasti A, Moreno B. Obesidad como factor de riesgo cardiovascular. Hipertensión y Riesgo Vascular;22, (1): 32-36